Price Alert

Neurocrine Biosciences In... (NBIX)

NASDAQ: NBIX · Real-Time Price · USD

137.03

0.29 (0.21%)

At close: Oct 03, 2025, 3:59 PM

137.03

0.00%

After-hours: Oct 03, 2025, 04:10 PM EDT

Neurocrine Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	2.51B	2.41B	2.36B	2.24B	2.12B	1.98B	1.89B	1.78B	1.67B	1.6B	1.49B	1.39B	1.3B	1.21B	1.13B	1.07B	1.03B	1.05B
Cost of Revenue	37.8M	35.7M	34M	33.2M	36.4M	38.7M	39.7M	38.9M	33.8M	27.1M	23.2M	19.6M	17.7M	16M	14.3M	13.1M	11.6M	10.9M
Gross Profit	2.47B	2.38B	2.32B	2.21B	2.08B	1.94B	1.85B	1.75B	1.64B	1.57B	1.47B	1.37B	1.28B	1.19B	1.12B	1.06B	1.02B	1.03B
Operating Income	495M	494.8M	570.5M	578.8M	536.2M	464.4M	250.9M	204M	150.6M	131.7M	249M	109.3M	66M	74.1M	102.5M	210.6M	121.8M	135.6M
Interest Income	20.6M	n/a	n/a	n/a	n/a	12M	12M	12M	12M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	527.1M	466.2M	486M	521.6M	446.9M	469.9M	332.1M	251.8M	234.1M	89.2M	213.9M	82.2M	14.8M	95.6M	101.4M	156.9M	69.3M	95M
Net Income	348.3M	305.8M	341.3M	385.9M	339.2M	369.7M	249.7M	191M	176.4M	64M	154.5M	58.2M	12.2M	71.4M	89.6M	444.8M	364.7M	402M
Selling & General & Admin	1.08B	1.04B	1.01B	938.3M	908.2M	888M	887.6M	851.6M	833.7M	794.7M	752.7M	726.3M	694.6M	655M	583.3M	533.3M	491.2M	444.5M
Research & Development	888.1M	834.9M	731.1M	683M	630.2M	584.9M	565M	545.5M	511M	501.1M	463.8M	433.2M	418.2M	357.1M	328.1M	307.4M	283.8M	289.9M
Other Expenses	4.1M	6.6M	12.5M	9.5M	8.5M	6M	143.9M	143.9M	143.9M	143.9M	n/a	100.3M	100.3M	105.3M	105.3M	5M	123.5M	164.5M
Operating Expenses	1.98B	1.88B	1.75B	1.63B	1.55B	1.48B	1.6B	1.54B	1.49B	1.44B	1.22B	1.26B	1.21B	1.12B	1.02B	845.7M	898.5M	898.9M
Interest Expense	n/a	49.7M	50.8M	51.9M	53M	4.6M	4.6M	4.6M	4.7M	5.6M	7.1M	12.6M	18M	22M	25.8M	27M	28.9M	31M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.01B	1.92B	1.78B	1.66B	1.58B	1.52B	1.64B	1.58B	1.52B	1.47B	1.24B	1.28B	1.23B	1.13B	1.03B	858.8M	910.1M	909.8M
Income Tax Expense	178.8M	160.4M	144.7M	135.7M	107.7M	100.2M	82.4M	60.8M	57.7M	25.2M	59.4M	24M	2.6M	24.2M	11.8M	-287.9M	-295.4M	-307M
Shares Outstanding (Basic)	99M	99.7M	100M	101.1M	100.8M	99.8M	98.4M	97.9M	97.6M	97.1M	96.3M	95.8M	95.6M	95.3M	94.9M	94.7M	94.6M	94.2M
Shares Outstanding (Diluted)	101M	102.5M	102.9M	104.3M	103.9M	103.6M	102.3M	101.1M	100.2M	97.1M	100.8M	99M	95.6M	97.6M	94.9M	97.7M	97.7M	98.2M
EPS (Basic)	3.48	3.03	3.38	3.85	3.42	3.76	2.54	1.96	1.83	0.67	1.61	0.61	0.13	0.76	0.95	4.75	3.89	4.30
EPS (Diluted)	3.38	2.95	3.29	3.73	3.31	3.63	2.42	1.86	1.73	0.60	1.53	0.57	0.11	0.72	0.91	4.57	3.72	4.10
EBITDA	557.2M	559.5M	639.7M	663M	618.4M	589.9M	381.2M	299.6M	256M	112.1M	236.6M	109M	45.8M	129.3M	138.1M	194M	107.7M	135M
EBIT	528.7M	531M	612.6M	637.3M	593.7M	567.4M	359.9M	279.6M	237.5M	94.8M	221M	94.8M	32.8M	117.6M	127.2M	183.9M	98.2M	126M
Depreciation & Amortization	28.5M	28.5M	27.1M	25.7M	24.7M	22.5M	21.3M	20M	18.5M	17.3M	15.6M	14.2M	13M	11.7M	10.9M	10.1M	9.5M	9M